Literature DB >> 13115983

Recent studies on the immunity response to administration of different plague vaccines.

K F MEYER.   

Abstract

Evaluation of the immunity produced by plague vaccines was made by measurement of the reactions in the body fluids of man and different animals to demonstrate altered refractoriness. Four serological methods were used: the agglutination test, the complement-fixation test, the passive mouse-protection test, and the haemagglutination test. Results showed that the majority of animal and human hosts, in response to injections of Pasteurella pestis, vigorously develop antibodies which may persist in the peripheral blood serum for several months.Critical tests to establish the correlation between antibody response following inoculation with plague antigens or vaccines and resistance to infection showed that inoculation of 30mug of Fraction I antigen consistently protected mice against P. pestis infection and that there is a definite correlation between the appearance of serum antibodies and the immunity state of the mice. There is a similar correlation in guinea-pigs, although the immunogenicity of antigens and vaccines for these animals is very variable. Primates are rendered resistant to massive infection with 1,000,000,000 to 2,000,000,000 viable P. pestis by suspensions of formalin-killed bacilli and by heat- or chemically-killed broth vaccine administered in the customary human dose; basic immunization with Fraction I renders approximately 60% of monkeys immune.Evidence from experiments carried out on groups of human volunteers points to the conclusion that any plague vaccine containing 2-3 mg of Fraction I or capable of producing that amount when inoculated into the body will favourably alter the susceptibility of 50% of inoculated persons. But, to alter favourably the responsiveness of a greater percentage and to enhance the moderately effective immunity, re-inoculation at intervals of 3-6 months is essential.

Entities:  

Keywords:  PLAGUE/prevention and control; VACCINES AND VACCINATION

Mesh:

Substances:

Year:  1953        PMID: 13115983      PMCID: PMC2542137     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  The comparative retention of antigen in the skin of immune and normal rabbits as determined with egg albumin labelled with radioactive iodine.

Authors:  L KORNGOLD; G L STAHLY; M C DODD; W G MYERS
Journal:  J Immunol       Date:  1953-04       Impact factor: 5.422

2.  Studies on immunization against plague. IV. The method of the hemagglutination test and some observations on the antigen.

Authors:  T H CHEN
Journal:  J Immunol       Date:  1952-12       Impact factor: 5.422

3.  Studies on immunization against plague. II. The complement-fixation test.

Authors:  T H CHEN; S F QUAN; K F MEYER
Journal:  J Immunol       Date:  1952-02       Impact factor: 5.422

4.  Direction of research on vaccination against influenza; new studies with immunologic adjuvants.

Authors:  J E SALK; A M LAURENT; M L BAILEY
Journal:  Am J Public Health Nations Health       Date:  1951-06
  4 in total
  5 in total

1.  A filtered non-toxic plague vaccine which protects guinea-pigs and mice.

Authors:  H Smith; L P Packman
Journal:  Br J Exp Pathol       Date:  1966-02

2.  Human immune response to a plague vaccine comprising recombinant F1 and V antigens.

Authors:  E D Williamson; H C Flick-Smith; C Lebutt; C A Rowland; S M Jones; E L Waters; R J Gwyther; J Miller; P J Packer; M Irving
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Effectiveness of live or killed plague vaccines in man.

Authors:  K F Meyer
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

4.  Mechanisms of long and short term immunity to plague.

Authors:  A Wake; H Morita; M Wake
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

5.  Peptidoglycan-Free Bacterial Ghosts Confer Enhanced Protection against Yersinia pestis Infection.

Authors:  Svetlana V Dentovskaya; Anastasia S Vagaiskaya; Mikhail E Platonov; Alexandra S Trunyakova; Sergei A Kotov; Ekaterina A Krasil'nikova; Galina M Titareva; Elizaveta M Mazurina; Tat'yana V Gapel'chenkova; Rima Z Shaikhutdinova; Sergei A Ivanov; Tat'yana I Kombarova; Vladimir N Gerasimov; Vladimir N Uversky; Andrey P Anisimov
Journal:  Vaccines (Basel)       Date:  2021-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.